✦ LIBER ✦

Apixaban for Reduction In Stroke and Other ThromboemboLic Events in Atrial Fibrillation (ARISTOTLE) trial: Design and rationale

✍ Scribed by Renato D. Lopes; John H. Alexander; Sana M. Al-Khatib; Jack Ansell; Raphael Diaz; J. Donald Easton; Bernard J. Gersh; Christopher B. Granger; Michael Hanna; John Horowitz; Elaine M. Hylek; John J.V. McMurray; Freek W.A. Verheugt; Lars Wallentin

Book ID: 116191876
Publisher: Elsevier Science
Year: 2010
Tongue: English
Weight: 372 KB
Volume: 159
Category: Article
ISSN: 1097-6744
DOI: 10.1016/j.ahj.2009.07.035

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Apixaban for Reduction In Stroke and Oth

Apixaban for Reduction In Stroke and Other ThromboemboLic Events in Atrial Fibrillation (ARISTOTLE) trial: Design and rationale

✍ Renato D. Lopes; John H. Alexander; Sana M. Al-Khatib; Jack Ansell; Raphael Diaz 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 372 KB

Atrial fibrillation (AF) is associated with increased risk of stroke that can be attenuated with vitamin K antagonists (VKAs). Vitamin K antagonist use is limited, in part, by the high incidence of complications when patients' international normalized ratios (INRs) deviate from the target range. The

Efficacy and Safety of Apixaban Compared

Efficacy and Safety of Apixaban Compared with Warfarin for Stroke Prevention in Patients with Atrial Fibrillation from East Asia: A Subanalysis of the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) Trial

✍ Goto, Shinya; Zhu, Jun; Liu, Lisheng; Oh, Byung-Hee; Wojdyla, Daniel M.; Aylward 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 356 KB

APIXABAN REDUCES HOSPITALIZATION IN PATI

APIXABAN REDUCES HOSPITALIZATION IN PATIENTS WITH ATRIAL FIBRILLATION: AN ANALYSIS OF THE EFFECT OF APIXABAN THERAPY ON RESOURCE USE IN THE APIXABAN FOR REDUCTION IN STROKE AND OTHER THROMBOEMBOLIC EVENTS IN ATRIAL FIBRILLATION TRIAL

✍ Cowper, Patricia A.; Pan, Wenqin; Anstrom, Kevin; Stafford, Judith; Lopes, Renat 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 147 KB

Improving outcomes in patients with atri

Improving outcomes in patients with atrial fibrillation: Rationale and design of the Early treatment of Atrial fibrillation for Stroke prevention Trial

✍ Kirchhof, Paulus; Breithardt, Günter; Camm, A. John; Crijns, Harry J.; Kuck, Kar 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 215 KB

D-dimer and risk of thromboembolic and b

D-dimer and risk of thromboembolic and bleeding events in patients with atrial fibrillation - observations from the ARISTOTLE trial

✍ Christersson, C.; Wallentin, L.; Andersson, U.; Alexander, J. H.; Ansell, J.; De 📂 Article 📅 2014 🏛 John Wiley and Sons 🌐 English ⚖ 299 KB

Apixaban compared with warfarin in patie

Apixaban compared with warfarin in patients with atrial fibrillation and previous stroke or transient ischaemic attack: a subgroup analysis of the ARISTOTLE trial

✍ J Donald Easton; Renato D Lopes; M Cecilia Bahit; Daniel M Wojdyla; Christopher 📂 Article 📅 2012 🏛 The Lancet 🌐 English ⚖ 264 KB